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The study was conducted to evaluate the anti-peptic ulcer activity of ethanol extract of Camellia sinensis (green tea) 
induced by Helicobacter pylori in Sprague Dawley rats. The standard regimen of anti-peptic ulcer agents, clarithromycin 
30 mg/kg, amoxicillin 30 mg/kg and esomeprazole 3 mg/kg used as the positive control. The rats divided into 6 groups 
(n = 6), normal control, vehicle control (2% of tragacanth suspension), positive control for preventive and treatment 
groups, preventive and treatment groups were given 50 mg/kg orally of green tea extract for 14 days before and after 
inoculation (as prevention and treatment, respectively) with 5×108 CFU/mL H. pylori suspension orally twice daily for 
7 days. Anti-peptic ulcer activity was evaluated based on the pH of gastric juice, ulcer score and body weight of rats. 
The results demonstrated that the use of green tea for prevention or treatment showed a significant difference (p<0.001) 
in reducing the pH of gastric juice 3.88 ± 0.09 and 5.74 ± 0.08, respectively, compared to vehicle control 5.85 ± 0.12. 
Meanwhile, vehicle control rats had high significantly reduced body weight when compared with all groups treated. 
The preventive and the treatment groups showed significantly reduce in ulcer score to 0.50 ± 0.18 (p<0.01) and 0.83 
± 0.10 (p<0.05), respectively, compared to vehicle control 1.50 ± 0.22. Meanwhile, it was comparable to the positive 
control. In conclusion, H. pylori suspension 5×108 CFU/mL given orally twice daily for seven days able to induce ulcer 
in Sprague Dawley rats, and the green tea extract 50 mg/kg was comparable to the standard regimen as anti-peptic 
ulcer agent. 
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ABSTRAK
Kajian ini dijalankan untuk menilai aktiviti anti-ulser peptik ekstrak etanol Camellia sinensis (teh hijau) yang 
diaruhkan oleh Helicobacter pylori pada tikus Sprague Dawley. Regimen piawai agen anti-ulser peptik, klaritromisin 
30 mg/kg, amoksisilin 30 mg/kg dan esomeprazol 3 mg/kg digunakan sebagai kawalan positif. Tikus dibahagikan kepada 
6 kumpulan (n = 6), kawalan normal, kawalan pembawa (2% suspensi tragacanth), kawalan positif untuk kumpulan 
pencegahan dan rawatan, kumpulan pencegahan dan rawatan yang diberikan ekstrak teh hijau 50 mg/kg secara oral 
selama 14 hari sebelum atau selepas inokulasi (sebagai kumpulan pencegahan dan rawatan) berserta dengan pemberian 
ampaian 5×108 CFU/mL H. pylori secara oral sebanyak dua kali sehari selama 7 hari. Aktiviti anti-ulser peptik dinilai 
berdasarkan pH jus gastrik, skor ulser dan berat badan tikus. Keputusan menunjukkan bahawa penggunaan teh 
hijau untuk pencegahan atau rawatan menunjukkan perbezaan yang signifikan (p<0.001) dalam mengurangkan pH 
jus gastrik 3.88 ± 0.09 dan 5.74 ± 0.08, setiap satu, berbanding dengan kawalan pembawa 5.85 ± 0.12. Sementara itu, 
terdapat penurunan berat badan yang ketara dalam tikus kawalan pembawa apabila dibandingkan dengan semua 
kumpulan yang dirawat. Kumpulan pencegahan dan rawatan menunjukkan penurunan skor ulser menjadi 0.50 ± 
0.18 (p<0.01) dan 0.83 ± 0.10 (p<0.05), berbanding kawalan pembawa 1.50 ± 0.22. Ia adalah setanding dengan 
kawalan positif. Sebagai kesimpulan, pemberian ampaian H. pylori 5×108 CFU/mL diberikan secara oral dua kali 
setiap hari selama tujuh hari dapat menyebabkan ulser pada tikus Sprague Dawley dan ekstrak teh hijau 50 mg/kg 
adalah setanding dengan regimen piawai sebagai agen anti-ulser peptik.
Kata kunci: Anti-ulser peptik; Camellia sinensis; ekstrak teh hijau; Helicobacter pylori; skor ulser 
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INTRODUCTION
Peptic ulcer diseases comprise heterogeneous disorder 
which manifests as a break in the lining of the 
gastrointestinal mucosa bathed by acid and pepsin. 
Generally, this happens due to the imbalance between 
gastric aggressive and mucosal defensive factors. Based 
on the site of the attack, peptic ulcer disease embraces 
both gastric and duodenal ulcer. The etiology of peptic 
ulcer is influenced by any aggressive factor and protective 
factors such as acid-pepsin secretion, parietal cell, mucus 
secretion, mucosal barrier, cellular regeneration, and 
endogenous protective agent prostaglandin and epidermal 
growth factor (Adinortey et al. 2013). Other factors are 
contributing to this disease, such as bad dietary habit, 
excessive intake of a non-steroidal anti-inflammatory 
agent, hereditary stress predisposition, and Helicobacter 
pylori infection. 
Helicobacter pylori, a Gram-negative and helical 
rod causes chronic gastritis and peptic ulcer and essential 
factor in gastric cancer occurrence. Epidemiological 
studies showed a strong correlation between H. pylori 
infections and peptic ulcer (Elseweidy et al. 2010). H. 
pylori eradication accelerates peptic ulcer healing and 
reduces the recurrence of gastric ulcer. Nowadays, triple 
therapies consisting of two antibiotics, and a proton pump 
inhibitor show high eradication rates. Unfortunately, 
H. pylori rapidly acquire resistance to some antibiotic 
through certain gene mutation mechanism. Soon, antibiotic 
resistance will be the most significant obstacles in the 
treatment of H. pylori. Besides, several pharmaceutical 
drugs recommended for peptic ulcer management provoke 
many adverse effects; abdominal discomfort, diarrhoea, 
and nausea. Because of that, a new alternative regimen 
with highly effective and safe is required for the treatment 
of H. pylori infection. Recently, there have been growing 
interests in alternative therapies, especially from plant 
sources, because of easy accessibility and affordability. It 
had been reported that various medicinal plants extracts 
have antibacterial activity. Thus, this plant may contain 
a new antibacterial agent that has potential as a new 
therapeutic agent. 
Tea is considered one of the most popular beverages, 
especially in China and Japan. Green tea (Camellia 
sinensis) is prepared from the withered leaves are 
steamed and then dried relatively rapid after plucking 
process to minimize chemical and enzyme reaction 
polyphenol oxidase (PPO). The green tea (GT) contains 
catechin included in polyphenol group which susceptible 
to be oxidized by PPO enzyme. The major polyphenolic 
compound in tea is the flavan-3-ols called catechins 
which include epicatechin (EC), epigallocatechin (EGC), 
epicatechin gallate (ECG), epigallocatechingallate 
(EGCG), gallocatechin (GC), and gallocatechin gallate 
(GCG). Due to the possession of phenolic hydroxyl group 
attached to flavon-3-ol structure has been associated 
with the ability of tea to scavenge free radical, thereby 
attracting tremendous research interest (Amić et al. 2003). 
It has been reported that tea catechins have antibacterial 
activity against various foodborne pathogenic bacteria 
(Mabe et al. 1999). Ultimately, the previous study has 
shown that polyphenol group compound able to inhibit 
Vac-A, which play an essential role for H. pylori in its 
survival other than urease enzyme in the stomach (Tombola 
et al. 2003). Thus, it seems reasonable to explore the 
possibility of using GT for the eradication of H. pylori. It 




The GT leaves were purchased from a food and beverage 
department in Kuala Lumpur, Malaysia with the brand 
Ujinotsuyu and the name of the product is Aoyanagi 
Green. The GT was in loose tea leaves form and the type 
of GT used was Bancha.
 
BACTERIA
H. pylori were maintained on columbia blood agar 
(Merck KGaA, Darmstadt, Germany) supplemented 
with 10% lake horse blood (Thermo Fisher Scientific 
USA) and H. pylori selective supplement (DENT) (Oxoid 
Limited, Thermo Fisher Scientific) at 37 ºC (atmosphere: 
5% CO2 or 95% air) for up to 5 to 7 days. The bacteria 
were confirmed as H. pylori strain by gram staining, 
oxidase, catalase and urease positive test.
CHEMICAL AND MEDIA
The chemicals and media used in this study were 
ethanol 100% (Merck Germany), tragacanth powder, 
clarithromycin 500 mg tablet (Abott Laboratories, 
Malaysia), amoxycillin trihydrate 500 mg capsule (CCM, 
Malaysia), esomeprazole 40 mg tablet (AstraZeneca, 
Malaysia), laked Horse blood and H. pylori selective 
supplement (BUMI-PHARMA, Malaysia), horse blood 
serum (Thermo Fischer Scientific, Malaysia), mueller-




The apparatus and instruments used in this study were oral 
gavages, micropipette 100 - 1000 µL (Socorex, Switzerland), 
CO2 incubator (Thermo Fischer Scientific, USA), rotary 
evaporator (BUCHI, Switzerland), ultrasonicator (Branson 
USA), UV-Visible spectrophotometer (Shimadzu, Japan), 
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electronic balance (Segatec, Malaysia), laminar flow 
cabinet class II (CLYDEC-APAC, Australia), autoclave (FC 
BIOS, Malaysia), freeze dryer (Thermo fisher scientific, 
Malaysia) and pH meter.
ANIMAL
A total of 40 adult male healthy Sprague Dawley rats 
weighing between 150 - 250 g were obtained and 
purchased from Laboratory Animal Resources Unit, 
Universiti Kebangsaan Malaysia. All rats were given 7 
days of acclimation period for adaptation. The rats were 
placed at standard controlled room (± 25 °C and cycle 
of 12-h light and 12-h dark).  Rats were supplied with 
standard laboratory food pellets and water ad libitum. The 
experimental procedure used in this study was approved 
by the Universiti Kebangsaan Malaysia Animal Ethics 
Committee (UKMAEC) with approval number FF/2015/
ENDANG/20-MAY/6881-MAY-2015-JAN 2016.
METHODS
PREPARATION AND STANDARDIZATION OF GT EXTRACTS
The product was ground into coarse powder using a 
mechanical grinder which was then macerated by soaking 
it in 80% ethanol at a ratio of 1:5 w/v for three days at room 
temperature (30 °C) with occasional shaking. After the 
extraction was completed, filtration was carried out and 
the filtrates were concentrated using a rotatory evaporator 
at 40 °C to yield a crude extract of GT. Standardization of 
GT extract was performed using kaempferol and quercetin 
as standards. Chromatographic column was performed 
using a reverse phase HPLC (Waters, Milford, MA, USA) 
equipped with Water Breeze system. XBridgeTM 
Column C50 5 μm (4.60 × 250 mm particle diameter, 
5 μm; Thermo Scientific, USA) (Waters, Ireland) was 
used for separation. The mobile phase for kaempferol 
and quercetin consisted of 0.05% orthophosphoric acid 
and acetonitrile at a ratio 50:50 (v/v) and methanol: 
acetonitrile: deionized water at a ratio 60:20:20 v/v/v, 
respectively. The flow rate of the mobile phase was set at 
0.3 mL/min with 20 μL of injection volume. Kaempferol 
was detected at 360 nm and quercetin at 262 nm. Validation 
of the HPLC method was carried out by determining the 
linearity, precision, limits of quantification and detection 
(Azmi et al. 2018).
DOSE PREPARATION OF GT AND DRUGS
Camellia sinensis, amoxicillin, clarithromycin, and 
esomeprazole were suspended in tragacanth 2%. The GT 
extract dose used was 50 mg/kg and for drugs doses such 
as clarithromycin, amoxicillin, and esomeprazole were 
30, 30, and 3 mg/kg, respectively (Adinortey et al. 2013). 
All the samples were administered through oral gavage 
method and weights of rat were measured throughout the 
experiment. 
PREPARATION OF BACTERIAL INOCULUMS ON BLOOD 
AGAR MEDIUM
The H. pylori inoculums on blood agar medium was 
performed according to Xu et al. (2010). Briefly a number 
of viable isolated colonies of H. pylori culture were 
inoculated on blood agar medium incubated in CO2 
incubator with humidity tray at 37 °C and 5% CO2 for 72 
to 92 h. However, H. pylori was passaged every 3 to 5 days. 
PREPARATION OF BACTERIAL INOCULUMS SUSPENSION
The H. pylori suspension were prepared from bacterial 
inoculums above to the universal bottles containing 
Mueller-hinton broth, 10% horse serum and 0.1% yeast 
extract liquid medium. The suspension was incubated 
for 24 h at 37 °C in 5% CO2. Enumeration of H. pylori 
suspension was done using UV-Vis spectrophotometer 
reading at 450 nm until the final concentration of H. 
pylori was 108 CFU/mL (Shahamat et al. 1991; Xia et al. 
1993).
EXPERIMENTAL ANTI-PEPTIC ULCER
The rats were divided into 6 groups (n = 6) as normal 
control group, vehicle control group, positive control 
of prevention and treatment groups, prevention and 
treatment groups (Burkitt et al. 2017). In the prevention 
and treatment experiments, vehicle control rats were 
given 1 mL/rat of tragacanth 2% suspension, positive 
control groups were given clarithromycin (30 mg/kg), 
amoxicillin (30 mg/kg) and esomeprazole (3 mg/kg) 
and the prevention and treatment groups were given GT 
extract 50 mg/kg orally once a day for 14 days before and 
after, respectively, being inoculated orally with 1 mL/rat 
of H. pylori suspension (5×108 CFU/mL) twice daily at 
an interval for 4 h for 7 days. At day-1 after the last day 
of inoculation for the prevention group and the last day 
of treatment for the treatment group, the rats were all 
sacrificed by cervical dislocation after anaesthesia and 
rapidly excised the stomach. Gastric content was collected 
to determine pH of gastric juice. Stomach was then opened 
along greater curvature washed with saline to record the 
ulcer score. 
ANTI-PEPTIC ULCER ACTIVITY EVALUATION
Macroscopic examination carried out based on grading 
0-5 scale. The following scoring in Table 1 was used to 
evaluate the ulcer as well as the severity of gastric lesion 
(Mahmood et al. 2009; Sonwjaya et al. 2016).
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TABLE 1. Ulcer score and its description
Ulcer score Description
0 No lesion (normal stomach)
0.5 hyperaemia (red coloration)/hemorrhagic spot
1 1 - 5 small ulcer (< 1 mm) with/without hemorrhagic spot,
2 1 - 5 small ulcer (1 mm - 2 mm) with/without hemorrhagic spot
3 more than five small lesions or one intermediate lesion (3 mm - 4 mm) with/without hemorrhagic spot
4 2 or more intermediate lesion or one gross lesion (4 mm) with/without hemorrhagic spot
5 perforated ulcer with/without hemorrhagic spot
Data were analyzed statistically by one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test using GraphPad Prism 5. All the data were 
expressed as mean ± SEM (n=6). p value <0.05 is considered as statistical significant. 
 
RESULTS 
STANDARDIZATION OF GT EXTRACTS
Validation of the HPLC method was carried out and the 
kaempferol and quercetin calibration curves plotted were 
linear within the concentration range of 13 to 200 μg/
mL and 31 to 500 μg/mL, respectively, with a correlation 
coefficient (r2) of 0.9878 and 0.9961 also, respectively. 
The retention time of kaempferol in the GT extract was 
14.280 min whilst for kaempferol standard was 14.750 
min. Furthermore, the retention time for quercetin in the 
GT extract and its standard were 2.518 and 2.738 min, 
respectively. The concentration of kaempferol in GT extract 
was 3.10 mg/g and quercetin was 0.8 mg/g.
ANTI-PEPTIC ULCER OF GT EXTRACT
Table 2 shows that the treatment and preventive 
groups using GT extract 50 mg/kg had significant 
different value in lowering pH of gastric juice 
(p<0.001) when compared to vehicle control. The 
capacity to decrease the pH of gastric juice in prevention 
and treatment groups with pH of 3.88 ± 0.09 (p<0.001) 
and 5.74 ± 0.08 (p<0.001), respectively, showed lower 
than their own positive controls. 
TABLE 2. Anti-peptic ulcer effect of Camellia sinensis induced by H. pylori in Sprague Dawley rats in experimental anti-peptic 
ulcer
Experimental pH of gastric juice Ulcer score Body weight (g)
Healthy (normal control) rats 2.36 ±0.17*** 0 253.32 ± 5.85***
Vehicle control group 5.85 ± 0.12 1.50 ± 0.22 149.66 ± 8.32
Positive control of preventive 
group 2.65 ± 0.24
*** 0.58 ± 0.20** 253.83 ± 16.48***
Preventive group with GT extract 3.88 ± 0.09*** 0.50 ± 0.18** 249.67 ± 6.73***
Positive control of treatment group 4.31 ± 0.21*** 0.66 ± 0.16* 229.66 ± 0.03***
Treatment group with GT extract 5.74 ± 0.08*** 0.83 ± 0.10* 197.00 ± 13.35***
Normal control was healthy rats without inoculation neither treatment, vehicle control was inoculated with H. pylori without prevention or treatment. Positive control of 
prevention and treatment groups were given the standard regimen (30 mg/kg clarithromycin, 30 mg/kg amoxicillin, 3 mg/kg esomeprazole) before and after inoculated 
with H. pylori, respectively. *, **, *** significant with p value <0.05, <0.01 and <0.001, respectively, compared with vehicle control. Values were expressed in mean ± 
SEM. N = 6
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In term of ulcer score evaluation, the anti-peptic ulcer 
effect of GT extract in preventive group and treatment 
group had significant different ulcer score 0.50 ± 0.18 
(p<0.01) and 0.83 ± 0.10 (p<0.05), respectively, compared 
to negative control that produce more ulcer 1.50 ± 0.22. 
Contrary, these values were not significant different or 
comparable with their own positive control (Table 1, 
Figures 1 & 2).
FIGURE 1. Representative picture of vehicle control group, positive control preventive 
group and preventive group with GT extract. Av bw: average of body weight; Av pH: 
average pH of gastric juice; Av uL score: average of ulcer score. All groups were 
inoculated with H. pylori 5 × 108 CFU/mL twice daily for 7 days after 14 days treatment 
(a) Vehicle control, (b) positive control of preventive group with standard regimen (30 
mg/kg clarithromycin, 30 mg/kg amoxicillin, 3 mg/kg esomeprazole), and (c) preventive 
group with 50 mg/kg GT extract. *, **, *** significant with p value <0.05, <0.01 and 
<0.001 respectively compared with vehicle control. Values mean ± SEM. N = 6
FIGURE 2. Representative picture of vehicle control group, positive control treatment group and 
treatment group with GT extract. Av bw: average of body weight; Av pH: average pH of gastric 
juice; Av uL score: average of ulcer score. All groups were inoculated with H. pylori 5 × 108 
CFU/mL twice daily for 7 days before 14 days treatment (a) Vehicle control, (b) positive control 
of treatment group with standard regimen (30 mg/kg clarithromycin, 30 mg/kg amoxicillin, 3 
mg/kg esomeprazole), and (c) treatment group with 50 mg/kg GT extract. *, **, ***: significant 
with p value <0.05, <0.01 and <0.001 respectively compared with vehicle control.  
ns: non 
significant compared with negative control. Values mean ± SEM. N = 6
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Moreover, the vehicle control group showed decrease 
in body weight with high significant difference with 
value 149.66 ± 8.32 (p<0.001) compared with all groups in 
the study (Table 1). From the three parameters determined 
in this study, it was found that Camellia sinensis extract at 
dose 50 mg/kg had a potency to decrease the pH of gastric 
juice, to reduce the ulcer score and to increase the body 
weight of rats.
DISCUSSION
Human H. pylori have difficulty to infect and produce 
peptic ulcer in rodent as an animal model. In 1996, 
however, Hirayama et al. (1996) reported that a Mongolian 
gerbil (MG) is a good model of human H. pylori infection, 
with the bacteria detectable throughout a 12-month study 
period with the results of chronic active gastritis, peptic 
ulcers resemble lesions apparent in man (Hirayama et 
al. 1996). Moreover, Werawatganon (2014) established 
a simple rat model of chronic H. pylori infection using 
Sprague-Dawley rats to develop chronic peptic ulcer. 
Our preliminary study was performed subjected to 
Werawatganon (2014) with a small modification. The 
results of our study showed that H. pylori suspended 
in Muller-Hinton broth 5 × 108 CFU/mL administered 
orally twice daily for 7 days able to induce peptic ulcer 
with ulcer score in range of 1.50 ± 0.22 to 3.00 ± 1.00 in 
Sprague Dawley rats and the effective dose of Camellia 
sinensis extract was 50 mg/kg. The number of H. pylori 
and the treatment of GT extract were used for anti-peptic 
ulcer experiment.  
In this experimental anti-peptic ulcer effect of 
Camellia sinensis, 50 mg/kg of plant extract been 
implemented to be used in rats based on the preliminary 
test result. This dose determined from the preliminary 
study and showed the anti-peptic ulcer activity. Parameters 
that been used to evaluate anti-peptic ulcer activity were 
pH of gastric juice, ulcer score, and the average weight 
of rats. These parameters were presented in the previous 
study done by Nair et al. (2010).
In our study, the pH of gastric juice in preventive 
and treatment groups using Camellia sinensis extract is 
lower significantly difference compared to the vehicle 
control but they showed higher pH compared with their 
positive control. It approved that positive control more 
effective in maintaining the pH of gastric juice to normal 
range compared to the test group. It indicated that plant 
extract had anti-peptic ulcer effects but not comparable 
with standard regimen (30 mg/kg clarithromycin, 30 mg/
kg amoxicillin, and 3 mg/kg esomeprazole) in decreasing 
pH. Esomeprazole, a drug that targets specifically to 
inhibit H(+)/K(+)-exchanging ATPase), which is a gated 
channel that regulates gastric acid secretion and pH of 
gastric juice. To maintain the normal pH of gastric juice 
when infected by H. pylori, the GT extract was not strong 
enough compared with the triple standard regimen with a 
specific mechanism of action. Based on the previous study 
carried out by Prabha et al. (2011), Musa sapientum-treated 
animal causes an increase in pH of gastric juice because 
of the ability of Musa sapientum extract inhibit the HCI 
(Prabha et al. 2011). However, this study showed that 
Camellia sinensis extract had a lower ability to maintain 
and regulate the pH of gastric juice compared to standard 
regimen (positive control).
Tea is consumed in three basic forms: GT, black 
tea (BT), and oolong tea (OT). Although BT accounts 
for 80% of the total tea consumption, studies on the 
pharmacological properties of BT are scarce. The tea 
polyphenols, especially the catechins are primarily 
responsible for the curing property of GT, however, during 
the production of BT, a significant part of the catechins 
is converted to the theaflavins (TF) (comprising of 
theaflavin-3-gallate, theaflavin-3’-gallate, and theaflavin- 
3,3’-digallate) and thearubigins by a polyphenol oxidase 
(Adhikary at al. 2011). Study by Adhikary at al. (2011) 
also showed that the biochemical transformation of GT 
into BT did not hamper the ulcer healing property, and 
also established TF as the active antiulcerogenic principle 
of BT. Both BT and TF were found to exert their action 
by augmenting mucosal antioxidant defense, protecting 
mucin and increasing the cyclooxygenase (COX-) 
derived prostaglandin E (PGE) synthesis in male Swiss 
albino mice was ulcer-induced by indomethacin. Their 
results are consistent with the anti-inflammatory property 
of TF. Based on the available evidence, the therapeutic 
effect of these BT and FT samples could be related to 
their antioxidant, mucin-protecting, and PGE-enhancing 
properties (Adhikary at al. 2011).
Our study has used H. pylori infection as an ulcer 
inducer in Sprague Dawley Rats treated with ethanol 
extract of Camellia sinensis (GT). The chemical contents 
of GT have been established such as catechin included 
in polyphenol group which susceptible to be oxidized 
by polyphenol oxidase (PPO) enzyme. The major 
polyphenolic compound in the GT is the flavan-3-ols 
called catechins which include epicatechin (EC), 
epigallocatechin (EGC), epicatechin gallate (ECG), 
epigallocatechingallate (EGCG), gallocatechin (GC) and 
gallocatechin gallate (GCG). Due to the possession of 
phenolic hydroxyl group attached to flavon-3-ol structure 
has been associated with the ability of GT to scavenge free 
radical, thereby attracting tremendous research interest 
(Amić et al. 2003). It has been reported that GT catechins 
have antibacterial activity against various foodborne 
pathogenic bacteria (Mabe et al. 1999). Ultimately, the 
previous study has shown that polyphenol group compound 
able to inhibit Vac-A, which play an essential role for 
H. pylori in its survival other than urease enzyme in the 
stomach (Tombola et al. 2003).  
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Furthermore, it has been suggested that VacA is a 
significant virulence factor of H. pylori by causing cell 
vacuolation and tissue damage by forming anion-selective, 
urea permeable channels in plasma and endosomal 
membranes. It has been activated by exposure to acid 
or basic pH (Palframan et al. 2012). Furthermore, it has 
been reported that VacA inhibitor such as phloretin had 
structural similarities with polyphenol such as flavonol, 
flavones, and isoflavone (Tombola et al. 2003). Besides, 
urease activity facilitates colonization either by producing 
ammonia which protects the acid sensitive bacteria in 
their transit across the gastric lumen to their final location 
below gastric mucus. The results of this study confirm 
that the urease activity not merely to modulate the pH but 
is also essential for colonization in vivo. The hypothesis 
state that without urease enzyme, the H. pylori cannot be 
able to survive in pH of gastric because H. pylori can 
only colonize and proliferate in alkaline gastric (Dunne 
et al. 2014). 
         The anti-peptic ulcer activity further evaluated based 
on the ulcer score. The results showed that preventive 
and treatment groups had significant differences in ulcer 
score values compared to vehicle control. Meanwhile, 
both groups showed comparable in ulcer score values 
with their positive control. It was demonstrated that 
Camellia sinensis extract is able to reduce the ulcer 
score at the same effectiveness with the standard regimen 
(clarithromycin, amoxicillin, and esomeprazole). The FDA 
already approved this standard regimen for their efficacy 
in treating peptic ulcer induced by H. pylori. The resistance 
of H. pylori towards antibiotics is worrying especially 
against metronidazole, which is the most common pattern 
of resistance worldwide (Savoldi et al. 2018). It had been 
reported that the resistance to other antibiotics had been 
risen because of gene mutation at certain protein will 
cause decrease drug binding and lead ineffectiveness of 
treatment (Mégraud et al. 2012). Hence it seems a good 
possibility for active substances in plants, especially GT 
leaves as an alternative for eradicating H. pylori and to 
overcome the possibility of resistant H. pylori against 
standard regimen. 
There was a significant decrease in the average 
body weight of rats in the vehicle control compared to 
all groups. Treatment with Camellia sinensis extract had 
increased significantly in average body weight of rats. 
The vehicle control rats consistently decreased in body 
weight throughout the experiment. This result showed that 
Camellia sinensis extract could stabilize the body weight 
compared to negative control rats. Overall, Camellia 
sinensis extract had anti-peptic ulcer activity comparable 
with the standard regimen. GT itself as a nutraceutical but 
it is possible to isolate the active compounds as anti- H. 
pylori infection.
CONCLUSION
From the results of our study, it can be concluded that H. 
pylori suspended in Muller-hinton broth 5 × 108 CFU/mL 
administrated orally twice daily for 7 days able to induce 
peptic ulcer with ulcer score in range of 1.50 ± 0.22 to 
3.00 ± 1.00 in Sprague Dawley rats. Furthermore, the 
Camellia sinensis extract was able to reduce the ulcer score 
with effectiveness comparable with standard regimen 
(clarithromycin, amoxicillin, and esomeprazole), but this 
extract had an ability to decrease the pH of gastric juice 
but is not as strong as standard regimen. It is seemed a 
good possibility for active substances in plants, especially 
GT leaves as an alternative to treat H. pylori infection and 
to overcome the possibility of resistant H. pylori against 
standard regimen with further study.       
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